跳至主要内容
临床试验/EUCTR2006-000708-18-LT
EUCTR2006-000708-18-LT进行中(未招募)不适用

Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - SHIFT

Institut de Recherches Internationales Servier0 个研究点目标入组 6,500 人开始时间: 2006年9月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
6,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - male or female patients >= 18 years
  • - Chronic Heart Failure
  • - left ventricular systolic dysfunction
  • - sinus rythm
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - unstable cardiovascular condition
  • - recent myocardial infarction or coronary revascularisation
  • - congenital heart diseases
  • - severe valvular disease
  • - active myocarditis

研究者

相似试验

进行中(未招募)
不适用
Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - SHIFTcardiac failure chronicMedDRA version: 9.0Level: PTClassification code 10007558
EUCTR2006-000708-18-FIInstitut de Recherches Internationales Servier6,500
进行中(未招募)
不适用
Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - SHIFT
EUCTR2006-000708-18-NLInstitut de Recherches Internationales Servier5,500
进行中(未招募)
不适用
Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - SHIFT
EUCTR2006-000708-18-LVInstitut de Recherches Internationales Servier5,500
进行中(未招募)
不适用
Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - SHIFTcardiac failure chronicMedDRA version: 9.0Level: PTClassification code 10007558
EUCTR2006-000708-18-ATInstitut de Recherches Internationales Servier6,500
进行中(未招募)
不适用
Effects of ivabradine on cardiovascular events in patients with stable coronary artery disease and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - BEAUTIF
EUCTR2004-001959-11-EEInstitut de Recherches Internationales Servier9,650
Effects of ivabradine on cardiovascular events in... | 临床试验